Advertisement
Document › Details
Reuters. (5/15/18). "News: Polyphor Prices IPO at 38 Sfr per Share". Zurich.
Organisation | Polyphor Ltd. (SIX: POLN) | |
Today | Spexis AG (SIX: SPEX) | |
Group | Spexis (Group) | |
Organisation 2 | SIX Swiss Exchange AG | |
Product | murepavadin (POL7080) | |
Product 2 | investment banking | |
Index term | Polyphor–SEVERAL: investment, 201804–201805 IPO CHF155m (€130m) at SIX Swiss Exchange at CHF38/share | |
Original document
accessed by [iito] on 2018-05-15
Record changed: 2023-06-05 |
Advertisement
More documents for Spexis (Group)
- [1] Spexis AG. (2/8/23). "Press Release: Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin (Ad hoc annuncement)". Allschwil....
- [2] Polyphor Ltd.. (29/10/21). "Press Release: Polyphor Shareholders Approve All Resolutions for the Planned Merger with EnBiotix at the Extraordinary General Meeting". Allschwil....
- [3] Polyphor Ltd.. (9/10/21). "Press Release: Polyphor and EnBiotix Announce Closing of Purchase Agreement of Inhaled Murepavadin by EnBiotix". Allschwil....
- [4] Polyphor Ltd.. (9/1/21). "Press Release: Polyphor and EnBiotix Announce Signing of Merger Agreement and Sale of Inhaled Murepavadin to EnBiotix". Allschwil....
- [5] Polyphor Ltd.. (7/16/21). "Press Release: Polyphor Provides Update on the Future of the FORTRESS Study of Balixafortide and Announces Initial Restructuring Steps". Allschwil....
- [6] Polyphor Ltd.. (6/28/21). "Press Release: Polyphor Provides Update on the Phase III FORTRESS Study of Balixafortide in Patients with Advanced HER2 Negative Breast cancer". Allschwil....
- [7] Polyphor Ltd.. (10/14/20). "Press Release: Polyphor Receives CARB-X Award of up to USD 18.44 Million to Support Development of New Antibiotic Program". Allschwil....
- [8] Polyphor Ltd.. (7/28/20). "Press Release: Polyphor Strengthens Financial Flexibility with CHF 19.3 million Equity-linked Financing". Allschwil....
- [9] Polyphor Ltd.. (1/23/20). "Press Release: Polyphor Appoints Gökhan Batur as Chief Executive Officer". Allschwil....
- [10] Polyphor Ltd.. (6/27/19). "Press Release: Polyphor Appoints Frank Weber as New Chief Medical and Development Officer". Allschwil....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top